roflumilast

Arcutis boasts positive data for topical Phase III candidate Roflumilast
Clinical Trials Arena
Fri, 11/18/22 - 11:36 am
Arcutis Biotherapeutics
roflumilast
clinical trials
One down, one to go: Arcutis' repurposed AstraZeneca drug clears first PhIII eczema trial
Endpoints
Tue, 11/15/22 - 06:35 pm
Arcutis Biotherapeutics
eczema
clinical trials
roflumilast
FDA Action Alert: Incyte, Arcutis Await Decisions in Vitiligo, Psoriasis
BioSpace
Mon, 07/18/22 - 10:22 am
FDA
Incyte
Arcutis Biotherapeutics
Opzelura
vitiligo
roflumilast
psoriasis
Forest Laboratories and Nycomed Receive Complete Response Letter for Roflumilast
Yahoo
Tue, 05/18/10 - 09:45 am
Forest Labs
Nycomed
FDA
roflumilast
bronchitis
COPD